{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:39:17Z","timestamp":1794487157990,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"am","delay-in-days":319,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jbspin.2023.105555","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T22:38:48Z","timestamp":1677278328000},"page":"105555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study"],"prefix":"10.1016","volume":"90","author":[{"given":"L\u00e9a","family":"Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Barnetche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gael","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Seneschal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Shipley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Pellegrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estibaliz","family":"Lazaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Constans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Duffau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Schaeverbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Richez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Kostine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Elise","family":"Truchetet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2023.105555_bib0225","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ard.62.8.728","article-title":"Risk of cancer in patients with scleroderma: a population based cohort study","volume":"62","author":"Hill","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2023.105555_bib0230","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/art.21225","article-title":"Risk of malignancy in scleroderma: a population-based cohort study","volume":"52","author":"Chatterjee","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2023.105555_bib0235","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/rheumatology\/kes303","article-title":"Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies","volume":"52","author":"Bonifazi","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2023.105555_bib0240","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1136\/annrheumdis-2018-212999","article-title":"Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer","volume":"77","author":"Igusa","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2023.105555_bib0245","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar4486","article-title":"Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma","volume":"16","author":"Moinzadeh","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2023.105555_bib0250","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/art.27549","article-title":"Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I\/III antibodies","volume":"62","author":"Shah","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2023.105555_bib0255","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jbspin.2023.105555_bib0260","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fimmu.2018.00449","article-title":"Gene profiling in patients with systemic sclerosis reveals the presence of oncogenic gene signatures","volume":"9","author":"Dolcino","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jbspin.2023.105555_bib0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ceb.2016.07.010","article-title":"Inflammation and cancer: tissue regeneration gone awry","volume":"43","author":"Pesic","year":"2016","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jbspin.2023.105555_bib0270","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jbspin.2019.09.015","article-title":"Systemic sclerosis: recent insight in clinical management","volume":"87","author":"Zanatta","year":"2020","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2023.105555_bib0275","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/jnci\/87.7.524","article-title":"Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma","volume":"87","author":"Travis","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jbspin.2023.105555_bib0280","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7326\/0003-4819-124-5-199603010-00003","article-title":"Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis","volume":"124","author":"Talar-Williams","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2023.105555_bib0285","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3899\/jrheum.080611","article-title":"Squamous cell carcinomas in 2 patients with diffuse scleroderma treated with mycophenolate mofetil","volume":"36","author":"Gulamhusein","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105555_bib0290","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2023.105555_bib0295","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2023.105555_bib0300","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.03112","article-title":"Intriguing relationships between cancer and systemic sclerosis: role of the immune system and other contributors","volume":"9","author":"Maria","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jbspin.2023.105555_bib0305","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2023.105555_bib0310","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/1744666X.2021.1847641","article-title":"Cancer risk in systemic sclerosis: identifying risk and managing high-risk patients","volume":"16","author":"Fragoulis","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jbspin.2023.105555_bib0315","first-page":"41","article-title":"Clinical features of systemic sclerosis patients with anti-RNA polymerase III antibody in a single centre in Spain","volume":"37","author":"Callejas-Moraga","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105555_bib0320","doi-asserted-by":"crossref","first-page":"103167","DOI":"10.1016\/j.autrev.2022.103167","article-title":"Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: data from the Spanish Scleroderma Registry (RESCLE)","volume":"21","author":"Carbonell","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2023.105555_bib0325","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1093\/rheumatology\/keab735","article-title":"Association between autoantibodies in systemic sclerosis and cancer in a national registry","volume":"61","author":"Hoa","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2023.105555_bib0330","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/rheumatology\/kep145","article-title":"Clinical significance of anti-Ro\/SSA-52kDa antibodies: a retrospective monocentric study","volume":"48","author":"Hervier","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2023.105555_bib0335","article-title":"Anti-SSA\/Ro52 autoantibodies in scleroderma: results of an observational, cross-sectional study","volume":"32","author":"S\u00e1nchez-Montalv\u00e1","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105555_bib0340","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00296-017-3718-1","article-title":"A review of the role and\u00a0clinical utility of anti-Ro52\/TRIM21 in systemic autoimmunity","volume":"37","author":"Lee","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2023.105555_bib0345","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/08916934.2012.732131","article-title":"Clinical associations of anti-SSA\/Ro60 and anti-Ro52\/TRIM21 antibodies: diagnostic utility of their separate detection","volume":"46","author":"Men\u00e9ndez","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jbspin.2023.105555_bib0350","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar3763","article-title":"Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis","volume":"14","author":"Hudson","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2023.105555_bib0355","first-page":"S131","article-title":"Monospecific anti-Ro52\/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival","volume":"33","author":"Wodkowski","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105555_bib0360","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/08923973.2021.1910833","article-title":"Presence of anti-TIF-1\u03b3, anti-Ro52, anti-SSA\/Ro60 and anti-Su\/Ago2 antibodies in breast cancer: a cross-sectional study","volume":"43","author":"V\u00e1zquez-Del Mercado","year":"2021","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.jbspin.2023.105555_bib0365","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/BOR.0b013e32834a5081","article-title":"Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications","volume":"23","author":"Shah","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105555_bib0370","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.autrev.2017.03.012","article-title":"Novel risk factors related to cancer in scleroderma","volume":"16","author":"Bernal-Bello","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2023.105555_bib0375","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jbspin.2023.105555_bib0380","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02154-2019","article-title":"The associations of interstitial lung abnormalities with cancer diagnoses and mortality","author":"Axelsson","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jbspin.2023.105555_bib0385","article-title":"Incidence of hepatocellular carcinoma in primary biliary cholangitis: a systematic review and meta-analysis","author":"Natarajan","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jbspin.2023.105555_bib0390","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s43046-020-0017-9","article-title":"Thyroid cancer associated with Hashimoto thyroiditis: similarities and differences in an endemic area","volume":"32","author":"Hussein","year":"2020","journal-title":"J Egypt Natl Canc Inst"},{"key":"10.1016\/j.jbspin.2023.105555_bib0395","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","article-title":"The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?","volume":"40","author":"Moeller","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jbspin.2023.105555_bib0400","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/rheumatology\/keaa287","article-title":"Rapidly progressive interstitial lung disease under FOLFOX treatment for colorectal cancer associated with systemic sclerosis: two case reports","volume":"60","author":"El-Hout","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2023.105555_bib0405","article-title":"Incidence, risk factors and outcomes of cancer in systemic sclerosis","author":"Morrisroe","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2023.105555_bib0410","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030853","article-title":"Biphasic temporal relationship between cancers and systemic sclerosis: a clinical series from Montpellier University Hospital and review of the literature","volume":"9","author":"Partouche","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jbspin.2023.105555_bib0415","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.rdc.2020.03.002","article-title":"Cancer and scleroderma","volume":"46","author":"Weeding","year":"2020","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jbspin.2023.105555_bib0420","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/art.38928","article-title":"Review: cancer-induced autoimmunity in the rheumatic diseases","volume":"67","author":"Shah","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105555_bib0425","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/BOR.0000000000000222","article-title":"Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening","volume":"27","author":"Shah","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105555_bib0430","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1172\/JCI80007","article-title":"Immunity, inflammation, and cancer: an eternal fight between good and evil","volume":"125","author":"Shalapour","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2023.105555_bib0435","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.41153","article-title":"Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis","volume":"72","author":"Nihtyanova","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105555_bib0440","doi-asserted-by":"crossref","first-page":"102583","DOI":"10.1016\/j.autrev.2020.102583","article-title":"Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets","volume":"19","author":"Mahler","year":"2020","journal-title":"Autoimmun Rev"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X23000349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X23000349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:30:40Z","timestamp":1761150640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X23000349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1297319X23000349"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2023.105555","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2023.105555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105555"}}